The Central Drugs Standard Control Organisation (CDSCO), CDSCO has granted manufacturing permission to private manufacturers for certain COVID-19 Vaccines for restricted use in emergency situation and to support vaccine manufacturing in India, the Government of India has launched ‘Mission COVID Suraksha- the Indian COVID- 19 Vaccine Development Mission’, being implemented by Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Undertaking (PSU) of Department of Biotechnology (DBT).
Under the Mission, clinical trial lot manufacturing of promising vaccine candidates including DNA vaccine candidate (ZydusCadila); mRNA vaccine candidate (Gennova Biopharmaceuticals); intranasal vaccine candidate (Bharat Biotech) are being supported.
Further, as part of efforts for the augmentation of Covaxin production, capacity enhancement of Bharat Biotech is being supported under Mission COVID Suraksha.
